SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Geronimo — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeronimo
Date of birth1829-06-01
IdentifiersMRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729
Document date1906-07-22
AuthorRoberta Whitehorse-Lindgren, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review of sleep, nightmares and drinking, seen the same day by psychiatry. [S]

History of Present Illness

Geronimo returns two weeks after intake, with the interpreter, and is seen the same day by Dr. Achebe-Varga, the visiting psychiatrist, who completed the CAPS-5 interview with him this morning. He still sleeps three or four hours a night, with nightmares most nights, and wakes ready to fight. He has cut his drinking from five or six drinks to three or four most evenings, and takes thiamine. His intake tests showed a PEth of 236 ng/mL, AST 58 and GGT 112 U/L with normal kidney function, albumin and bilirubin. A urine test today shows no opioids. He has not fallen again. He would like to try the talking treatment first and is not ready for a medicine for his mood; he will take a medicine for the drinking. [S]

ElementDetail
SleepThree or four hours; nightmares most nights
DrinkingThree or four drinks most evenings, down from five or six
PCL-554
CAPS-5Criteria met in all four symptom clusters; severity 44
Urine drug testNo opioids

Review of Systems

SystemResultFinding
PsychiatricPositiveNightmares, unwanted memories, startle and poor sleep; no thoughts of suicide
NeurologicalNegativeNo tremor, sweats or confusion when he drinks less
GastrointestinalNegativeNo abdominal pain, jaundice or black stools
MusculoskeletalNegativeLeft hip bruise healing; no pain on walking

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1906-07-08activeS
Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicinesOne tablet dailyOral route1906-07-22activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1906-07-22Body height173cmS
1906-07-22Body weight66.2kgS
1906-07-22Body mass index (BMI) [Ratio]22.1kg/m2S
1906-07-22Systolic blood pressure134mm[Hg]S
1906-07-22Diastolic blood pressure78mm[Hg]S
1906-07-22Heart rate78/minS
1906-07-22Respiratory rate16/minS
1906-07-22Body temperature36.5CelS
1906-07-22Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1906-07-22PTSD PCL-5 score [PCL-5]54{score}S

Physical Exam

Vital signs recorded on 1906-07-22; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 134/78, pulse 78; weight 66.2 kg
Mental statusAlert and composed; mood tired; affect restricted; no psychotic symptoms; no thoughts of suicide or of harming anyone
NeurologicalNo tremor; steady gait
AbdomenLiver edge not enlarged; no tenderness

Problems

ProblemClinical statusVerificationCodeProvenance
Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessedresolvedconfirmed G47.00S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep.
Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not metactiveconfirmed F43.12S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person.
Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinkingactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking.
A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 secondsactiveconfirmed Z91.81S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPTSD symptom severity (PCL-5)Baseline, then every visit during treatmentCompleted today54, from 56 at intake
SurveyStructured clinician-administered interview (CAPS-5) to confirm the diagnosisOnce at diagnosis; again only if the diagnosis is in doubtCompleted todayCriteria met in all four clusters (intrusion, avoidance, negative mood and thinking, arousal); severity score 44, recorded as narrative
Self-managementTrauma-focused psychotherapy (cognitive processing therapy), sessions attendedWeekly for twelve sessionsOrderedCognitive processing therapy booked weekly from next week, with the interpreter
SurveyDepressive symptoms (PHQ-9)Baseline, then monthly during active treatmentUp to datePHQ-9 11 at intake, item 9 scored 0; next at six weeks
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; no firearm; 988 card carried
Self-managementDrinking since the last visit, against his own goalEvery visitCompleted todayThree or four drinks most evenings, down from five or six
LaboratoryLiver tests (AST, ALT, GGT) on naltrexoneBefore starting, at four to six weeks, then every three to six monthsCompleted todayBefore naltrexone: AST 58, ALT 36, GGT 112 U/L at intake; AST under three times the upper limit; creatinine 1.0 mg/dL, eGFR 78
LaboratoryPEth, a blood marker of drinking over the past two to four weeksAt baseline and every one to three months during treatment, with consentUp to date236 ng/mL at intake; next at about eleven weeks
Medication safetyNaltrexone safety: opioid use, nausea, wallet cardAt the start and every visitCompleted todayUrine test negative for opioids; wallet card given
Medication safetySSRI safety: sodium, bleeding, falls and side effectsSodium within the first month in older adults; review at each dose changeNot indicatedNo SSRI; he chose therapy first
ExaminationFalls and gait (Timed Up and Go), orthostatic blood pressureAt intake and every visit after a fallUp to dateTimed Up and Go 13 seconds at intake; no fall since
Self-managementTraditional healing alongside clinic care, at his choiceEvery visitCompleted todayOffered again; his choice; nothing asked
ReferralPsychiatry consultationAt diagnosisCompleted todaySeen by Dr. Achebe-Varga today

Goal progress:

Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994)

Follow-up: Six-week review with liver tests. Cognitive processing therapy weekly from next week. Call the clinic or 988 at any hour. Next scheduled visit 1906-08-19: six-week review: cognitive processing therapy, naltrexone, sleep, mood and medicine. [S]